Home ~ About us ~ Ahead of print ~ Current Issue ~ Back Issues ~ Search ~ Instructions ~ Subscription ~ Advertise ~ Feedback ~ Login  
  Mens Sana Monographs
A Monograph Series Devoted To The Understanding Of Medicine, Mental Health, Man, Mind, Music And Their Matrix
 Why MSM | Acknowledgement | Call for papers... | Forthcoming MSM...  Users online: 1148  Home Email this article Print this Article Bookmark this page Decrease font size Default font size Increase font size 
This article has been cited by
1Possible natural therapeutics against schizophrenia and its acute and treatment resistant forms: a review
Abhijit Dey,Saheli Das,Anuradha Mukherjee
Journal of Biologically Active Products from Nature.2016;6(1)1
2Perfil clínico e sociodemográfico de pacientes com esquizofrenia refratária tratados em um centro terciário
Marceli Cezaretto,Ester Franco de Souza Freitas Silva,Ariane Ambrizzi,Victor Eduardo Dutra de Biase,Elissandro de Freitas Silva,Emirene Maria Trevisan Navarro da Cruz,Fabio Aparecido Borghi,Gerardo Maria de Araújo Filho
Jornal Brasileiro de Psiquiatria.2014;63(3)185
3Population Pharmacokinetics of Clozapine: A Systematic Review
Orwa Albitar,Sabariah Noor Harun,Hadzliana Zainal,Baharudin Ibrahim,Siti Maisharah Sheikh Ghadzi
BioMed Research International.2020;2020(3)1
4Clozapine underutilization in treatment-resistant schizophrenia
Robert J. Stanton,Chris Paxos,Werner J. Geldenhuys,B Pharm,Jessica L. Boss,Mark Munetz,Altaf S. Darvesh,M Pharm
Mental Health Clinician.2015;5(2)63
5Clotiapine in schizophrenia: a guide to its use
Katherine A. Lyseng-Williamson
Drugs & Therapy Perspectives.2015;31(11)365
6Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis
Andrew T. Olagunju,Scott R. Clark,Bernhard T. Baune
CNS Drugs.2018;32(11)1011
7Basal Exposure Therapy: A New Approach for Treatment-Resistant Patients with Severe and Composite Mental Disorders
Didrik Heggdal,Roar Fosse,Jan Hammer
Frontiers in Psychiatry.2016;7(11)1011
8Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials
Wei Zheng,Xiao-Lan Cao,Gabor S. Ungvari,Ying-Qiang Xiang,Tong Guo,Zheng-Rong Liu,Yuan-Yuan Wang,Brent P. Forester,Stephen J. Seiner,Yu-Tao Xiang,Peter John McKenna
PLOS ONE.2016;11(6)e0156510
9Clozapine: a guide to its use in patients with schizophrenia who are unresponsive to or intolerant of other antipsychotic agents
Katherine A. Lyseng-Williamson
Drugs & Therapy Perspectives.2013;29(6)161
10Mirtazapine adjunct for people with schizophrenia
Luke A Perry,Dhruvesh Ramson,Suzanne Stricklin
Cochrane Database of Systematic Reviews.2018;29(6)161
11Electroconvulsive therapy in treatment of resistant schizophrenia: biological markers of efficacy and safety
M. V. Ivanov,D. S. Zubov
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2019;119(3)92
12Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy
Debbi A. Morrissette,Stephen M. Stahl
CNS Spectrums.2014;19(5)439
13A pilot randomized controlled trial of the Occupational Goal Intervention method for the improvement of executive functioning in patients with treatment-resistant schizophrenia
Adriana D.B. Vizzotto,Diego L. Celestino,Patricia C. Buchain,Alexandra M. Oliveira,Graça M.R. Oliveira,Elaine S. Di Sarno,Isabel C. Napolitano,Helio Elkis
Psychiatry Research.2016;245(5)148
14Study of negatives symptoms in first episode schizophrenia
Vivek Bambole,Nilesh Shah,Shushma Sonavane,Megan Johnston,Amresh Shrivastava
Open Journal of Psychiatry.2013;03(03)323
15Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses
Felice Iasevoli,Camilla Avagliano,Benedetta Altavilla,Annarita Barone,Mariateresa Ciccarelli,Luigi D'Ambrosio,Danilo Notar Francesco,Eugenio Razzino,Michele Fornaro,Andrea de Bartolomeis
Psychiatry Research.2018;269(03)481
16Clozapine oral suspension (Versacloz™): a guide to its use in the USA
Katherine A. Lyseng-Williamson
Drugs & Therapy Perspectives.2014;30(6)193
17The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment
Andrea de Bartolomeis,Elisabetta F Buonaguro,Felice Iasevoli,Carmine Tomasetti
Journal of Psychopharmacology.2014;28(6)505
18Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment
Andrea de Bartolomeis,Livia Avvisati,Felice Iasevoli,Carmine Tomasetti
European Journal of Pharmacology.2013;718(1-3)502
19Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis
Saeed Ahmed,Ali Mahmood Khan,Hema Madhuri Mekala,Hema Venigalla,Rizwan Ahmed,Amira Etman,Michael Esang,Mustafa Qureshi
20Making clozapine safer: current perspectives on improving its tolerability
Bosky Nair,James Hunter MacCabe
Future Neurology.2014;9(3)313
21An ethanolic extract of Desmodium adscendens exhibits antipsychotic-like activity in mice
Patrick Amoateng,Samuel Adjei,Dorcas Osei-Safo,Kennedy K.E. Kukuia,Thomas K. Karikari,Alexander K. Nyarko
Journal of Basic and Clinical Physiology and Pharmacology.2017;28(5)313
22Mirtazapine (adjunct) versus placebo for schizophrenia
Suzanne Stricklin,Luke A Perry,Dhruvesh Ramson
Cochrane Database of Systematic Reviews.2015;28(5)313
23Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives
Frederick C. Nucifora,Edgar Woznica,Brian J. Lee,Nicola Cascella,Akira Sawa
Neurobiology of Disease.2019;131(5)104257
24The effect of transcranial direct current stimulation on psychotic symptoms of schizophrenia is associated with oxy-hemoglobin concentrations in the brain as measured by near-infrared spectroscopy: A pilot study
Zui Narita,Takamasa Noda,Shiori Setoyama,Kazuki Sueyoshi,Takuma Inagawa,Tomiki Sumiyoshi
Journal of Psychiatric Research.2018;103(5)5
25Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder
Marc Cantillon,Arul Prakash,Ajay Alexander,Robert Ings,Dennis Sweitzer,Laxminarayan Bhat
Schizophrenia Research.2017;189(5)126
26Stimulants for impulsive violence in schizophrenia spectrum disordered women: a case series and brief review
Philip Skoretz,Chin Tang
CNS Spectrums.2016;21(6)445
  Why MSM 
  Call for papers... 
  Forthcoming MSM... 
  My Preferences